US Stock MarketDetailed Quotes

XBIO Xenetic Biosciences

Watchlist
  • 2.319
  • -0.120-4.94%
Trading Apr 22 12:44 ET
3.58MMarket Cap-0.90P/E (TTM)
Intraday
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

Comments

    $Xenetic Biosciences (XBIO.US)$
    Xenetic Biosciences, Inc. Announces Entry by Collaboration Partner into a Clinical Study Agreement to Advance Development of DNase Platform for the Treatment of Relapsed/Refractory Osteosarcoma and Ewing Sarcoma
    Wednesday, 26th March at 9:00 am
    Investigator initiated study with collaboration partner, PeriNess, to be conducted at the Tel-Aviv Sourasky Medical Center
    FRAMINGHAM, MA / ACCESS Newswire / March 26, 2025 / Xenetic Biosciences, Inc. (NASDAQ: XBIO) ("Xe...
    $Xenetic Biosciences (XBIO.US)$
    Xenetic Biosciences Strengthens Cancer Research Pipeline While Maintaining $6.2M Cash Position
    Xenetic Biosciences, Inc. Reports Full Year 2024 Financial Results
    $Xenetic Biosciences (XBIO.US)$
    Xenetic Biosciences, Inc. Presents Positive Preclinical Data Underscoring the Potential of DNase I as an Adjunctive Treatment to Enhance Immunotherapeutic Responses
    Thursday, 13th March at 8:30 am
    Data presented at the Society for Immunotherapy of Cancer (SITC) Spring Scientific 2025 Cell Therapy Meeting
    Findings demonstrate that by degrading neutrophil extracellular traps (NETs), DNase I not only facilitates increased T cell infiltration but also restores T ce...
    $Xenetic Biosciences (XBIO.US)$ Xenetic Biosciences Presents Preclinical Data On DNase I Co-Administration With CAR T Cells, Highlighting Potential To Enhance Therapeutic Responses In Melanoma Lung Metastasis Model
    Benzinga· 9 mins ago
    Xenetic Biosciences Presents Preclinical Data On DNase I Co-Administration With CAR T Cells, Highlighting Potential To Enhance Therapeutic Responses In Melanoma Lung Metastasis Model
    $Xenetic Biosciences (XBIO.US)$
    Xenetic Biosciences, Inc. Presents Positive Preclinical Data Highlighting the Potential of Co-Administration of DNase I with CAR T Cells in a Murine Model of Melanoma Lung Metastasis
    Xenetic Biosciences (NASDAQ:XBIO)presented positive preclinical data showing the potential of co-administering DNase I with CAR T cells in treating melanoma lung metastasis. The study demonstrated that a single injection of DNase I (10 mg/kg) with EGFR-CAR T cells significantly sup...
Read more

Market Insights

U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More